Therapeutic implications of fibroblast growth factor receptor inhibitors in a combination regimen for solid tumors (Review)-Reference-Cited by-同舟云学术

Therapeutic implications of fibroblast growth factor receptor inhibitors in a combination regimen for solid tumors (Review)

Published:2020-07-10 Issue:3 Volume:20 Page:2525-2536
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Luo Hong¹,Zhang Tao¹,Cheng Peng¹,Li Dong¹,Ogorodniitchouk Oleksandr²,Lahmamssi Chaimaa²,Wang Ge³,Lan Meiling⁴

Affiliation:

1. Department of Oncology, General Hospital of Western Theater Command, Chengdu, Sichuan 610083, P.R. China

2. Institut de Cancérologie Lucien Neuwirth, 42270 Saint Priest en Jarez, France

3. Cancer Center, Institute of Surgical Research, Third Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, P.R. China

4. Cancer Center, The Third Affiliated Hospital of Chongqing Medical University (Jie Er Hospital), Chongqing 401120, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Open-label, dose-escalation FIGHT-101 study of pemigatinib combined with targeted therapy, chemotherapy, or immunotherapy in patients with advanced malignancies;ESMO Open;2024-07

2. Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers;International Journal of Molecular Sciences;2024-01-10

3. Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling;Frontiers in Pharmacology;2024-01-10

4. Extracellular Matrix Organization Genes Predict the Prognosis and Immune Microenvironment in Stomach Adenocarcinoma;2023-05-26

5. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention;Journal of Biomolecular Structure and Dynamics;2023-03-30